• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

德克萨斯州11年间马凡综合征患者胸主动脉介入治疗的结果。

Outcomes of thoracic aortic interventions in Marfan syndrome in the state of Texas over 11 years.

作者信息

Mikulski Matthew F, Well Andrew, Mery Carlos M, Johnson Gregory, Gottlieb Erin A, Fraser Charles D, Beckerman Ziv

机构信息

Department of Surgery and Perioperative Care, Dell Medical School, The University of Texas at Austin, Austin, TX, USA.

Texas Center for Pediatric and Congenital Heart Disease, UT Health Austin and Dell Children's Medical Center, Austin, TX, USA.

出版信息

Interdiscip Cardiovasc Thorac Surg. 2023 Aug 3;37(2). doi: 10.1093/icvts/ivad128.

DOI:10.1093/icvts/ivad128
PMID:37584655
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10438956/
Abstract

OBJECTIVES

Marfan syndrome is a heritable connective tissue disorder with significant aortopathy and conveys substantial cardiovascular morbidity. This study characterizes the mortality and morbidities of thoracic aortic interventions (TAI) in the Marfan syndrome population in the state of Texas from 2009 to 2019.

METHODS

A retrospective review of the Texas Inpatient Discharge Dataset from 1 January 2009 to 31 December 2019. Discharges from acute care hospitals with a Marfan syndrome diagnosis by the International Classification of Diseases 9/10 codes and a procedure code for TAI were analysed utilizing descriptive, univariate and multivariable regression statistics.

RESULTS

There were 4641 Marfan syndrome discharges identified, of whom 644 (13.9%) underwent TAI. Thoracic or thoraco-abdominal aortic dissection or rupture was noted in 223 (34.6%). Thirty-three (5.1%) had a concomitant coronary artery intervention. There were 30 (4.7%) in-hospital mortalities, 126 (19.6%) diagnoses of acute renal failure (ARF), 52 (8.1%) had mechanical ventilation >96 h and the median length of stay was 10 [interquartile range (IQR) 7-16] days. After adjustment, concomitant coronary artery intervention was associated with in-hospital mortality [odds ratio (OR) 3.69 [IQR 1.15-11.90], P = 0.029] and ARF (OR 2.66 [IQR 1.19-5.94], P = 0.017). Aortic dissections/ruptures were associated with ARF (OR 1.73 [IQR 1.14-2.63], P = 0.010), ventilation >96 h (OR 2.19 [IQR 1.21-3.97], P = 0.010), and 15% longer length of stay (95% confidence interval 2.4-29.1%, P = 0.038).

CONCLUSIONS

TAI are frequent among the hospitalized Marfan Syndrome population. Concomitant coronary intervention is associated with increased risk of death and aortic dissections/ruptures are associated with increased morbidity. The high prevalence of aortic dissections/ruptures points to a potential target for improving imaging surveillance, adherence to treatment guidelines and preventative management of Marfan syndrome aortopathy.

摘要

目的

马凡综合征是一种遗传性结缔组织疾病,伴有严重的主动脉病变,具有较高的心血管疾病发病率。本研究描述了2009年至2019年德克萨斯州马凡综合征患者胸主动脉介入治疗(TAI)的死亡率和发病率。

方法

对2009年1月1日至2019年12月31日的德克萨斯州住院患者出院数据集进行回顾性分析。利用描述性、单变量和多变量回归统计分析急性护理医院中通过国际疾病分类9/10编码诊断为马凡综合征且有TAI程序编码的出院病例。

结果

共识别出4641例马凡综合征出院病例,其中644例(13.9%)接受了TAI。223例(34.6%)出现胸主动脉或胸腹主动脉夹层或破裂。33例(5.1%)同时进行了冠状动脉介入治疗。住院死亡30例(4.7%),诊断为急性肾衰竭(ARF)126例(19.6%),机械通气>96小时52例(8.1%),中位住院时间为10天[四分位间距(IQR)7 - 16天]。调整后,同时进行冠状动脉介入治疗与住院死亡率相关[比值比(OR)3.69 [IQR 1.15 - 11.90],P = 0.029]和ARF相关(OR 2.66 [IQR 1.19 - 5.94],P = 0.017)。主动脉夹层/破裂与ARF相关(OR 1.73 [IQR 1.14 - 2.63],P = 0.010)、通气>96小时相关(OR 2.19 [IQR 1.21 - 3.97],P = 0.010)以及住院时间延长15%相关(95%置信区间2.4 - 29.1%,P = 0.038)。

结论

TAI在住院的马凡综合征患者中很常见。同时进行冠状动脉介入治疗与死亡风险增加相关,主动脉夹层/破裂与发病率增加相关。主动脉夹层/破裂的高患病率指出了改善影像监测、遵循治疗指南以及马凡综合征主动脉病变预防性管理的潜在目标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/87f6a99e73ef/ivad128f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/a718a840210a/ivad128f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/9cffe8cc3ab7/ivad128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/87f6a99e73ef/ivad128f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/a718a840210a/ivad128f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/9cffe8cc3ab7/ivad128f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fd5/10438956/87f6a99e73ef/ivad128f2.jpg

相似文献

1
Outcomes of thoracic aortic interventions in Marfan syndrome in the state of Texas over 11 years.德克萨斯州11年间马凡综合征患者胸主动脉介入治疗的结果。
Interdiscip Cardiovasc Thorac Surg. 2023 Aug 3;37(2). doi: 10.1093/icvts/ivad128.
2
Long-term outcomes in heritable thoracic aortic disease.遗传性胸主动脉疾病的长期预后
Front Cardiovasc Med. 2022 Oct 13;9:1009947. doi: 10.3389/fcvm.2022.1009947. eCollection 2022.
3
Outcomes of Thoracic Endovascular Aneurysm Repair (TEVAR) in Patients With Connective Tissue Disorders.结缔组织疾病患者胸主动脉腔内修复术(TEVAR)的疗效
Vasc Endovascular Surg. 2020 Nov;54(8):676-680. doi: 10.1177/1538574420945070. Epub 2020 Jul 30.
4
Trends of vascular surgery procedures in Marfan syndrome and Ehlers-Danlos syndrome.马凡综合征和埃勒斯-当洛综合征的血管外科手术趋势
Vascular. 2020 Dec;28(6):834-841. doi: 10.1177/1708538120925597. Epub 2020 May 19.
5
The risk for type B aortic dissection in Marfan syndrome.马凡综合征患者发生 B 型主动脉夹层的风险。
J Am Coll Cardiol. 2015 Jan 27;65(3):246-54. doi: 10.1016/j.jacc.2014.10.050.
6
Aortic dissection and ruptures in adult congenital heart disease in Texas from 2009 to 2019.2009年至2019年德克萨斯州成人先天性心脏病患者的主动脉夹层和破裂情况。
Eur J Cardiothorac Surg. 2022 Jan 24;61(2):309-317. doi: 10.1093/ejcts/ezab416.
7
Progressive aortic enlargement in medically managed acute type B aortic dissections with visceral aortic involvement.医学治疗的急性 B 型主动脉夹层伴内脏主动脉受累患者的主动脉进行性扩大。
J Vasc Surg. 2022 Dec;76(6):1466-1476.e1. doi: 10.1016/j.jvs.2022.08.004. Epub 2022 Aug 10.
8
Current status of thoracoabdominal aortic aneurysm repair in Marfan syndrome.马凡综合征胸主动脉瘤修复的现状
J Card Surg. 1997 Mar-Apr;12(2 Suppl):167-72.
9
Endovascular stent grafting and open surgical replacement for chronic thoracic aortic aneurysms: a systematic review and prospective cohort study.血管内支架移植物和开放手术治疗慢性胸主动脉瘤:系统评价和前瞻性队列研究。
Health Technol Assess. 2022 Jan;26(6):1-166. doi: 10.3310/ABUT7744.
10
Endovascular management of chronic aortic dissection in patients with Marfan syndrome.马凡综合征患者慢性主动脉夹层的血管内治疗
J Vasc Surg. 2009 Nov;50(5):987-91. doi: 10.1016/j.jvs.2009.05.056. Epub 2009 Jul 26.

本文引用的文献

1
Aortic dissection and ruptures in adult congenital heart disease in Texas from 2009 to 2019.2009年至2019年德克萨斯州成人先天性心脏病患者的主动脉夹层和破裂情况。
Eur J Cardiothorac Surg. 2022 Jan 24;61(2):309-317. doi: 10.1093/ejcts/ezab416.
2
Midterm outcomes of aortic root surgery in patients with Marfan syndrome: A prospective, multicenter, comparative study.马凡综合征患者主动脉根部手术的中期结果:一项前瞻性、多中心、比较性研究。
J Thorac Cardiovasc Surg. 2023 May;165(5):1790-1799.e12. doi: 10.1016/j.jtcvs.2021.08.064. Epub 2021 Sep 4.
3
Outcomes of endovascular therapy for Stanford type B aortic dissection in patients with Marfan syndrome.
马凡综合征患者 Stanford B 型主动脉夹层血管内治疗的结果。
J Thorac Cardiovasc Surg. 2023 Jun;165(6):1999-2007.e1. doi: 10.1016/j.jtcvs.2021.05.045. Epub 2021 Jun 9.
4
Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS).急性和慢性胸主动脉疾病中胸主动脉腔内修复术应用的当前选择与建议:欧洲心脏病学会(ESC)心血管外科工作组、ESC主动脉与外周血管疾病工作组、ESC经皮心血管介入欧洲协会(EAPCI)以及欧洲心胸外科学会(EACTS)的专家共识文件
Eur J Cardiothorac Surg. 2021 Jan 4;59(1):65-73. doi: 10.1093/ejcts/ezaa268.
5
Meta-analysis Examining the Usefulness of Angiotensin Receptor blockers for the Prevention of Aortic Root Dilation in Patients With the Marfan Syndrome.Meta 分析研究血管紧张素受体阻滞剂在马凡综合征患者预防主动脉根部扩张中的作用。
Am J Cardiol. 2020 Aug 1;128:101-106. doi: 10.1016/j.amjcard.2020.04.034. Epub 2020 May 19.
6
Aortic Complications in Marfan Syndrome: Should We Anticipate Preventive Aortic Root Surgery?马凡综合征的主动脉并发症:我们是否应预期预防性主动脉根部手术?
Ann Thorac Surg. 2020 Jun;109(6):1850-1857. doi: 10.1016/j.athoracsur.2019.08.096. Epub 2019 Oct 4.
7
Utilization of Laparoscopic Colon Surgery in the Texas Inpatient Public Use Data File (PUDF).德克萨斯州住院患者公共使用数据文件(PUDF)中腹腔镜结肠手术的应用情况。
JSLS. 2019 Jul-Sep;23(3). doi: 10.4293/JSLS.2019.00032.
8
Aortic Surgery Outcomes of Marfan Syndrome and Ehlers-Danlos Syndrome Patients at Teaching and Nonteaching Hospitals.教学医院和非教学医院中马凡综合征和埃勒斯-当洛综合征患者的主动脉手术结果。
Ann Vasc Surg. 2019 Feb;55:175-181.e3. doi: 10.1016/j.avsg.2018.07.052. Epub 2018 Oct 2.
9
Causes of Mortality in the Marfan Syndrome(from a Nationwide Register Study).马凡综合征患者的死亡原因(基于全国注册研究)。
Am J Cardiol. 2018 Oct 1;122(7):1231-1235. doi: 10.1016/j.amjcard.2018.06.034. Epub 2018 Jul 21.
10
Aortic dissection in patients with Marfan syndrome based on the IRAD data.基于国际急性主动脉夹层注册研究(IRAD)数据的马凡综合征患者的主动脉夹层
Ann Cardiothorac Surg. 2017 Nov;6(6):633-641. doi: 10.21037/acs.2017.10.03.